NEW YORK--Medical leaders and prostate cancer patient advocacy groups have joined with Immunex Corporation to launch Empowered Patients in Control (EPIC), an education program designed to help men with late-stage prostate cancer confront the physical and emotional issues related to their disease.
NEW YORK--Medical leaders and prostate cancer patient advocacy groupshave joined with Immunex Corporation to launch Empowered Patients in Control(EPIC), an education program designed to help men with late-stage prostatecancer confront the physical and emotional issues related to their disease.
Said spokesman Harry Belafonte, the noted singer/actor, "it isonly when we stare these problems in the face that we can truly seek tosolve them." Mr. Belafonte was diagnosed with prostate cancer aftera routine checkup and underwent prostatectomy last year.
The goal of the new program is to provide patients, their families,and their physicians with access to the latest information and tools necessaryto improve the management of pain commonly associated with advanced prostatecancer.
The components of EPIC are:
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Prolaris in Practice: Guiding ADT Benefits, Clinical Application, and Expert Insights From ACRO 2025
April 15th 2025Steven E. Finkelstein, MD, DABR, FACRO discuses how Prolaris distinguishes itself from other genomic biomarker platforms by providing uniquely actionable clinical information that quantifies the absolute benefit of androgen deprivation therapy when added to radiation therapy, offering clinicians a more precise tool for personalizing prostate cancer treatment strategies.